CN Patent

CN1882533A — 4－((苯氧基烷基)硫基)－苯氧基乙酸及其类似物

Assigned to Janssen Pharmaceutica NV · Expires 2006-12-20 · 19y expired

What this patent protects

本发明的特征在于4－((苯氧基烷基)硫基)－苯氧基乙酸及其类似物、含有它们的组合物及其使用方法，该化合物可作为PPARδ调节剂以治疗或抑制血脂异常等疾病的进展。

USPTO Abstract

本发明的特征在于4－((苯氧基烷基)硫基)－苯氧基乙酸及其类似物、含有它们的组合物及其使用方法，该化合物可作为PPARδ调节剂以治疗或抑制血脂异常等疾病的进展。

Drugs covered by this patent

seladelpar-lysine (SELADELPAR LYSINE)

Patent Metadata

Patent number: CN1882533A
Jurisdiction: CN
Classification: —
Expires: 2006-12-20
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.